Anavex Life Sciences Corp (AVXL)

[Jonjones325]

Please tell us why they matter at this point.

We seemingly have enough positive data to move on to designing a solid phase 3, which was the point of our phase 2.

The only way I can see the endpoints mattering now, is for a possible accelerated pathway and SP appreciation, which we could desperately use.

In the whole scheme of things, we have what we need to move on, with or without meeting endpoints. And that I believe can be viewed as a success.